Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Rhea-AI Summary

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) to participate in fireside chat at Stifel Healthcare Conference on Nov. 14, 2023, to discuss novel therapeutic for Alzheimer’s disease

Positive

• Participation in Stifel Healthcare Conference provides an opportunity for Acumen Pharmaceuticals to showcase their novel therapeutic approach for Alzheimer’s disease, potentially increasing investor interest and awareness.

Negative

• None.

CHARLOTTESVILLE, VA. and INDIANAPOLIS, IN., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today that management will participate in a fireside chat at the Stifel Healthcare Conference on Tuesday, Nov. 14, 2023 at 2:25 p.m. ET. The live webcast may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.

About Acumen Pharmaceuticals, Inc.

Acumen, headquartered in Charlottesville, VA, with additional offices in Indianapolis, IN and Newton, MA, is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD). Acumen’s scientific founders pioneered research on AβOs, which a growing body of evidence indicates are early and persistent triggers of Alzheimer’s disease pathology. Acumen is currently focused on advancing its investigational product candidate, ACU193, a humanized monoclonal antibody that selectively targets toxic soluble AβOs, following positive topline results in INTERCEPT-AD, a Phase 1 clinical trial involving early Alzheimer’s disease patients. For more information, visit www.acumenpharm.com.

Investors:
Alex Braun
abraun@acumenpharm.com

Media: 
AcumenPR@westwicke.com

FAQ

What is the purpose of Acumen Pharmaceuticals, Inc.'s participation in the Stifel Healthcare Conference on Nov. 14, 2023?

The purpose is to discuss their novel therapeutic targeting toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease.

Where can the live webcast of the fireside chat be accessed?

The live webcast can be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.

What time will the fireside chat take place on Nov. 14, 2023?

The fireside chat will take place at 2:25 p.m. ET.

What is the ticker symbol of Acumen Pharmaceuticals, Inc.?

The ticker symbol is ABOS and it is listed on NASDAQ.